A Prospective, Multicenter, Randomized Controlled Clinical Study on the Safety and Efficacy of Biolimus Drug-Coated Balloon (DCB) Versus Drug-Eluting Stent (DES) in the Treatment of De Novo Coronary Artery Lesions

NCT07582250 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

1548

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients With de Novo Coronary Artery Lesions

Interventions

DEVICE: Biolimus-Coated Coronary Artery Balloon Dilatation Catheter
DEVICE: Xinyue Drug-Coated Stent System

Sponsor

JW Medical Systems Ltd